Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID-19 AstraZeneca vaccination: A case report

Arsh Haj Mohamad Ebrahim Ketabforoush; Ghazale Molaverdi; Matineh Nirouei; Nahid Abbasi Khoshsirat

doi:10.1002/ccr3.6505

Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID-19 AstraZeneca vaccination: A case report

Clin Case Rep. 2022 Nov 15;10(11):e6505. doi: 10.1002/ccr3.6505. eCollection 2022 Nov.

Authors

Arsh Haj Mohamad Ebrahim Ketabforoush¹, Ghazale Molaverdi², Matineh Nirouei², Nahid Abbasi Khoshsirat³

Affiliations

¹ Cellular and Molecular Research Center Iran University of Medical Sciences Tehran Iran.
² Student Research Committee Alborz University of Medical Sciences Karaj Iran.
³ Department of Neurology, Clinical Research Development Unit (CRDU) of Shahid Rajaei Hospital Alborz University of Medical Sciences Karaj Iran.

Abstract

The patient was a 55-year-old female patient who presented with sudden onset of left hemiplegia, facial hemiparesis, and hypoesthesia. She has received her first dose of the AstraZeneca COVID-19 vaccine. This case indicates that vaccination may raise the hypercoagulable state even in a condition of post-ICH and anticoagulant prophylaxis.

Keywords: ChAdOx1 nCoV‐19 vaccine; Oxford‐AstraZeneca COVID‐19 vaccine; cerebral venous sinus thrombosis; intracerebral hemorrhage.

Publication types

Case Reports